Dekeryte, RutaHull, ClairePlucinska, KajaKhan, ShakilKamli-Salino, SarahMody, NimeshMorrice, NicolaMcLaughlin, ChrisGault, VictorPlatt, BettinaDelibegovic, Mirela2020-05-152020-05-152019-08-01Dekeryte, R, Hull, C, Plucinska, K, Khan, S, Kamli-Salino, S, Mody, N, Morrice, N, McLaughlin, C, Gault, V, Platt, B & Delibegovic, M 2019, 'Effects of Liraglutide and Fenretinide treatments on the diabetic phenotype of neuronal human BACE1 knock-in mice', Biochemical Pharmacology, vol. 166, pp. 222-230. https://doi.org/10.1016/j.bcp.2019.05.020, https://doi.org/10.1016/j.bcp.2019.05.0200006-2952Mendeley: 197a5679-7139-360f-982e-f82868fc668aORCID: /0000-0002-7852-0749/work/76976903ORCID: /0000-0002-2215-7952/work/147568359ORCID: /0000-0002-5107-5366/work/160390078ORCID: /0000-0001-6193-3152/work/160847650https://hdl.handle.net/2164/14321The authors would like to acknowledge University of Aberdeen PhD studentship to RD and Scottish Alzheimer’s Research UK Junior member research grant to RD to perform GLP-1 ELISA and Alzheimer’s Research UK grant to BP and MD (ARUK-PG2017B-11). We thank Dr Oliver Helk for advice concerning statistical analyses and Prof Gernot Riedel for kindly providing the PhenoTyper home cages and advice in behavioural studies.921257242engSDG 3 - Good Health and Well-beingBACE1Type 2 diabetesDPP4LiraglutideInsulin resistanceR Medicine (General)BiochemistryPharmacologyAlzheimers Research UKARUK-PG2017B-11R1Journal article10.1016/j.bcp.2019.05.020https://linkinghub.elsevier.com/retrieve/pii/S0006295219301959http://www.mendeley.com/research/effects-liraglutide-fenretinide-treatments-diabetic-phenotype-neuronal-human-bace1-knockin-micehttp://www.scopus.com/inward/record.url?scp=85066461300&partnerID=8YFLogxK166